Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

pradimicin FA 2

Known as: D-Serine, N-((5-((4-amino-4,6-dideoxy-3-O-beta-D-xylopyranosyl-beta-D-galactopyranosyl)oxy)-5,6,8,13-tetrahydro-1,6,9,14-tetrahydroxy-11-methoxy-3-methyl-8,13-dioxobenzo(a)naphthacen-2-yl)carbonyl)-, (5S-trans)-, pradimicin FA-2 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
DNA-damaging agents are widely used in cancer therapy; however, their use is limited by dose-related toxicities, as well as the… Expand
  • table 1
  • table 2
  • figure 2
  • figure 3
  • figure 4
2000
2000
In order to clarify the mechanism of the calcium-activated anti-fungal action of pradimicin derivatives, we investigated the… Expand
1999
1999
The pradimicins are a new class of antifungal agents with activity against the majority of human fungal pathogens. In this study… Expand
1999
1999
The dynamic structure of the antifungal antibiotic pradimicin BMY-28864 in D2O and its interaction with calcium ions were… Expand
1998
1998
Pradimicin BMY-28864 (Pm) is an antibiotic effective against yeasts and fungi, and is known to bind mannose in the presence of… Expand
1993
1993
Several pradimicin-family antibiotics have recently been found to possess potent antifungal activity, while their aglycones are… Expand
  • figure 1
  • table 1
  • table 3
  • table 2
  • table 4
1990
1990
Pradimicin FA-1 was produced via directed biosynthesis with substitution of D-serine for D-alanine in the 15-position of… Expand